- Home
- Publications
- Publication Search
- Publication Details
Title
New Drug Targets for the Treatment of Obesity
Authors
Keywords
-
Journal
CLINICAL PHARMACOLOGY & THERAPEUTICS
Volume 90, Issue 1, Pages 40-51
Publisher
Springer Nature
Online
2011-06-08
DOI
10.1038/clpt.2011.82
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- It Takes Two to Tango
- (2016) Jean L. Chan et al. JOURNAL OF INVESTIGATIVE MEDICINE
- Crossing the Hurdles of Thyroid Hormone Receptor-α Activation
- (2011) Miriam O. Ribeiro et al. ENDOCRINOLOGY
- Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomised, placebo-controlled, phase 3 trial
- (2011) Kishore M Gadde et al. LANCET
- The effect of the triple monoamine reuptake inhibitor tesofensine on energy metabolism and appetite in overweight and moderately obese men
- (2010) A Sjödin et al. INTERNATIONAL JOURNAL OF OBESITY
- Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
- (2010) Frank L Greenway et al. LANCET
- Multicenter, Placebo-Controlled Trial of Lorcaserin for Weight Management
- (2010) Steven R. Smith et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of Sibutramine on Cardiovascular Outcomes in Overweight and Obese Subjects
- (2010) W. Philip T. James et al. NEW ENGLAND JOURNAL OF MEDICINE
- Weight Loss With Naltrexone SR/Bupropion SR Combination Therapy as an Adjunct to Behavior Modification: The COR-BMOD Trial
- (2010) Thomas A. Wadden et al. Obesity
- New approaches to the pharmacological treatment of obesity: Can they break through the efficacy barrier?
- (2010) G.A. Kennett et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- The Neurokinin 1 Receptor Antagonist, Ezlopitant, Reduces Appetitive Responding for Sucrose and Ethanol
- (2010) Pia Steensland et al. PLoS One
- Comparison of Combined Bupropion and Naltrexone Therapy for Obesity with Monotherapy and Placebo
- (2009) Frank L. Greenway et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- A TRβ-selective agonist confers resistance to diet-induced obesity
- (2009) Beatriz S Amorim et al. JOURNAL OF ENDOCRINOLOGY
- Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study
- (2009) Arne Astrup et al. LANCET
- Enhanced Weight Loss With Pramlintide/Metreleptin: An Integrated Neurohormonal Approach to Obesity Pharmacotherapy
- (2009) Eric Ravussin et al. Obesity
- Effect of tesofensine on bodyweight loss, body composition, and quality of life in obese patients: a randomised, double-blind, placebo-controlled trial
- (2008) Arne Astrup et al. LANCET
- Rational Design of a Combination Medication for the Treatment of Obesity
- (2008) Frank L. Greenway et al. Obesity
- Lorcaserin (APD356), a Selective 5-HT2CAgonist, Reduces Body Weight in Obese Men and Women
- (2008) Steven R. Smith et al. Obesity
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started